PharmaLive: Merck Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients With Early Signs of Multiple Sclerosis
Links shared publicly online about this topic.
- 0total visits
PharmaLive: Merck Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients With Early Signs of Multiple Sclerosis
PharmaLive: Merck Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients With Early Signs of Multiple Sclerosis
View full resource at pharmalive.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Rebif, Merck & Co.
Most Recently Shared on November 18, 2011 at 6:00 pm By:
#Merck #Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients w/Early Signs of #MS: http://t.co/pCuGHH16
Advertisement
